Onderneming RepliCel Life Sciences Inc. Toronto S.E.
Aandelen
RP
CA76027P4006
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,055 CAD | -.--% | -.--% | -15,38% |
Vakgebied
Aantal werknemers: 1
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cell Replication Technology
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schutte
CEO | Chief Executive Officer | 35 | 14-12-18 |
Rolf Hoffmann
FOU | Founder | 63 | - |
Kevin McElwee
FOU | Founder | 54 | - |
David Kwok
DFI | Director of Finance/CFO | - | 16-08-23 |
David Hall
CHM | Chairman | 71 | 22-12-10 |
Ben Austring
COO | Chief Operating Officer | 41 | 28-11-22 |
Robert Buckler
BRD | Director/Board Member | 58 | 01-10-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 22-12-10 |
Peter Lewis
BRD | Director/Board Member | 69 | 27-05-11 |
Rolf Hoffmann
FOU | Founder | 63 | - |
Robert Buckler
BRD | Director/Board Member | 58 | 01-10-14 |
Gary Boddington
BRD | Director/Board Member | 56 | 01-06-21 |
Andrew Schutte
CEO | Chief Executive Officer | 35 | 14-12-18 |
Peter Lowry
BRD | Director/Board Member | 61 | 14-12-18 |
Jamie Mackay
BRD | Director/Board Member | - | 09-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 61 429 672 | 24 249 871 ( 39,48 %) | 0 | 39,48 % |
Bedrijfsgegevens
RepliCel Life Sciences, Inc.
570 Granville Street Suite 900
V6C 3P1, Vancouver
+604 248 8730
http://www.replicel.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 115 mld. | |
+13,17% | 107 mld. | |
-12,76% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-7,19% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+6,67% | 14,26 mld. | |
+33,90% | 12,37 mld. | |
-28,60% | 8,28 mld. |
- Beurs
- Aandelen
- Koers REPC.F
- Koers RP
- Onderneming RepliCel Life Sciences Inc.